biosimilars adoption

Three Barriers to Biosimilar AdoptionUnderstanding the key barriers to biosimilar adoption in the U.S. is the first step managed care executives can take to overcome these obstacles, according to a Trinity Parners report.
The Obstacles That Impede Biosimilars
The Obstacles That Impede BiosimilarsHurdles to adoption of biosimilars include regulatory issues and lack of interchangeability with the reference drugs.